E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/27/2016 in the Prospect News PIPE Daily.

Arch Therapeutics negotiates $3.4 million brokered placement of units

Agent Maxim Group helps to sell 9.5 million units at $0.36 per unit

By Devika Patel

Knoxville, Tenn., May 27 – Arch Therapeutics Inc. said it will raise about $3.4 million in a private placement of units. Maxim Group LLC is the agent.

The company will sell about 9.5 million units of one common share and 0.75 warrants at $0.36 per unit.

Each whole warrant will be exercisable at $0.438 for five years. The strike price reflects a 0.46% discount to the May 26 closing share price of $0.44.

The life science company is based in Dublin, Ireland.

Issuer:Arch Therapeutics Inc.
Issue:Units of one common share and 0.75 warrants
Amount:$3.4 million (approximate)
Units:9.5 million (approximate)
Price:$0.36
Warrants:0.75 warrants per unit
Warrant expiration:Five years
Warrant strike price:$0.438
Agent:Maxim Group LLC
Pricing date:May 27
Stock symbol:OTCBB: ARTH
Stock price:$0.44 at close May 26
Market capitalization:$47.32 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.